After the adoption of the opinion of the Agency, the applicant asked the Commission whether the representative product and use presented in the application fall under the scope provided for in Article 2 of Regulation (EU) No 528/2012, considering Regulation (EU) 2017/745 of the European Parliament and of the Council [Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1, ELI: http://data.europa.eu/eli/reg/2017/745/oj).].
Recital 7, Decision_act (EU) 2025/1074
In forcesince 2 Jun 2025
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…2Law
Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January…Law
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 Novembe…Law
- celex=31990L0385
- celex=31993L0042
- num:eu=1990/385
- num:eu=1993/42